Late‐onset hypogonadism: Reductio ad absurdum of the cardiovascular risk‐benefit of testosterone replacement therapy
Andrology2020Vol. 8(6), pp. 1614–1627
Citations Over TimeTop 10% of 2020 papers
Abstract
Attempts to demonstrate that TRT damages the cardiovascular system via systematic analysis of the putative mechanisms led to the contradiction of the initial hypothesis. Current evidence indicates that TRT is safe once other comorbidities are addressed.
Related Papers
- → Effects of resveratrol on endothelial nitric oxide synthase (eNOS) phosphorylation and interaction with regulatory proteins(2008)1 cited
- Acute vasoreactivity testing with sildenafil vs nitric oxide in patients with PAH(2012)
- Sildenafil and the Treatment of Pulmonary Hypertension(2008)
- → Sildenafil Citrate for Women(2018)
- → Sildenafil And Hypoxic Pulmonary Hypertension(2007)